• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期的痰液细菌培养及药敏试验
J Family Med Prim Care. 2022 Dec;11(12):7713-7719. doi: 10.4103/jfmpc.jfmpc_576_22. Epub 2023 Jan 17.
2
C-reactive protein levels predict bacterial exacerbation in patients with chronic obstructive pulmonary disease.C 反应蛋白水平可预测慢性阻塞性肺疾病患者的细菌恶化。
Am J Med Sci. 2013 Mar;345(3):190-4. doi: 10.1097/MAJ.0b013e318253c921.
3
Sputum bacteriology and clinical response to antibiotics in moderate exacerbation of chronic obstructive pulmonary disease.慢性阻塞性肺疾病中度加重期的痰液细菌学及对抗生素的临床反应
Clin Respir J. 2018 Apr;12(4):1424-1432. doi: 10.1111/crj.12671. Epub 2017 Aug 11.
4
Impact of diurnal temperature variations on sputum bacterial detection in hospitalized patients with acute COPD exacerbation: a retrospective study from Fuzhou, China.昼夜温差对急性 COPD 加重住院患者痰细菌检测的影响:来自中国福州的一项回顾性研究。
BMC Pulm Med. 2024 Jun 22;24(1):291. doi: 10.1186/s12890-024-03102-w.
5
Real-life data on antibiotic prescription and sputum culture diagnostics in acute exacerbations of COPD in primary care.基层医疗中慢性阻塞性肺疾病急性加重期抗生素处方及痰培养诊断的真实世界数据。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 13;12:285-290. doi: 10.2147/COPD.S120510. eCollection 2017.
6
Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期对抗生素耐药的微生物。
Respir Res. 2018 Jun 15;19(1):119. doi: 10.1186/s12931-018-0820-1.
7
Bacterial Isolates and Antibacterial Resistance Patterns in a Patient with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in a Tertiary Teaching Hospital, Southwest Ethiopia.埃塞俄比亚西南部一家三级教学医院中一名慢性阻塞性肺疾病急性加重患者的细菌分离株及抗菌药物耐药模式
Can J Infect Dis Med Microbiol. 2022 Aug 31;2022:9709253. doi: 10.1155/2022/9709253. eCollection 2022.
8
Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.慢性阻塞性肺疾病严重急性加重患者中的多重耐药菌:患病率、危险因素及转归
Crit Care Med. 2006 Dec;34(12):2959-66. doi: 10.1097/01.CCM.0000245666.28867.C6.
9
Sputum color as a marker of acute bacterial exacerbations of chronic obstructive pulmonary disease.痰液颜色作为慢性阻塞性肺疾病急性细菌感染加重的一项指标。
Respir Med. 2005 Jun;99(6):742-7. doi: 10.1016/j.rmed.2004.10.020. Epub 2004 Dec 10.
10
[Clinical study on optimal switching mode in sequential noninvasive-invasive mechanical ventilation for acute exacerbation of chronic obstructive pulmonary disease].[慢性阻塞性肺疾病急性加重期序贯无创-有创机械通气最佳切换模式的临床研究]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Feb;32(2):161-165. doi: 10.3760/cma.j.cn121430-20190923-00030.

本文引用的文献

1
Study of respiratory viruses and their coinfection with bacterial and fungal pathogens in acute exacerbation of chronic obstructive pulmonary diseases.慢性阻塞性肺疾病急性加重期呼吸道病毒及其与细菌和真菌病原体合并感染的研究
Lung India. 2021 Jan-Feb;38(1):53-58. doi: 10.4103/lungindia.lungindia_273_20.
2
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary updated 2003.慢性阻塞性肺疾病全球诊断、管理和预防策略:2003年更新版《慢性阻塞性肺疾病全球倡议执行摘要》
COPD. 2004 Apr;1(1):105-41; discussion 103-4. doi: 10.1081/COPD-120030163.
3
Exacerbations and progression of disease in asthma and chronic obstructive pulmonary disease.哮喘和慢性阻塞性肺疾病的病情加重与进展
Proc Am Thorac Soc. 2004;1(2):88-92. doi: 10.1513/pats.2306026.
4
Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重频率与肺功能下降之间的关系。
Thorax. 2002 Oct;57(10):847-52. doi: 10.1136/thorax.57.10.847.
5
Microbial pattern of acute infective exacerbation of chronic obstructive airway disease in a hospital based study.一项基于医院的研究中慢性阻塞性气道疾病急性感染性加重的微生物模式
Indian J Chest Dis Allied Sci. 2001 Jul-Sep;43(3):157-62.
6
Toward a consensus definition for COPD exacerbations.迈向慢性阻塞性肺疾病急性加重的共识定义。
Chest. 2000 May;117(5 Suppl 2):398S-401S. doi: 10.1378/chest.117.5_suppl_2.398s.
7
Antibiotic therapy of exacerbations of chronic bronchitis.慢性支气管炎急性加重期的抗生素治疗。
Semin Respir Infect. 2000 Mar;15(1):59-70. doi: 10.1053/srin.2000.0150059.
8
Treatment of chronic obstructive pulmonary disease and its exacerbations in general practice. EOLO Group. Estudio Observacional de la Limitación Obstructiva al Flujo aEreo.全科医疗中慢性阻塞性肺疾病及其急性加重的治疗。EOLO 研究组。气道阻塞受限的观察性研究。
Respir Med. 1999 Mar;93(3):173-9. doi: 10.1016/s0954-6111(99)90004-5.
9
Outcomes following acute exacerbation of severe chronic obstructive lung disease. The SUPPORT investigators (Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments).重度慢性阻塞性肺疾病急性加重后的预后。SUPPORT研究人员(了解治疗结果和风险的预后及偏好研究)。
Am J Respir Crit Care Med. 1996 Oct;154(4 Pt 1):959-67. doi: 10.1164/ajrccm.154.4.8887592.
10
Hospital and 1-year survival of patients admitted to intensive care units with acute exacerbation of chronic obstructive pulmonary disease.因慢性阻塞性肺疾病急性加重入住重症监护病房患者的住院及1年生存率
JAMA. 1995 Dec 20;274(23):1852-7.

慢性阻塞性肺疾病急性加重期的痰液细菌培养及药敏试验

Sputum antibiogram in acute exacerbation of chronic obstructive pulmonary disease.

作者信息

Manjhi Rekha, Nanda Sushant Kumar, Agrawal Babul Kumar

机构信息

Department of Pulmonary Medicine, VSS Institute of Medical Science and Research, Sambalpur University, Burla, Odisha, India.

出版信息

J Family Med Prim Care. 2022 Dec;11(12):7713-7719. doi: 10.4103/jfmpc.jfmpc_576_22. Epub 2023 Jan 17.

DOI:10.4103/jfmpc.jfmpc_576_22
PMID:36994009
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10041001/
Abstract

BACKGROUND

Bacterial infections are the most common reason for acute exacerbation of chronic obstructive pulmonary disease (AECOPD). This can range from self-limited disease to respiratory failure requiring mechanical ventilation and is associated with increased mortality and morbidity in survivors.

AIM

To ascertain common antibiotics effective in AECOPD using sputum bacterial culture and antibiotic susceptibility testing. Materials and Methods: In the present cross-sectional observational study, we analysed the sputum antibiogram in 237 patients who had not received antibiotics in the past 48 hours. Statistical analysis was performed, and the χ test was used to determine the associations between categorical variables. A value ≤0.05 was considered significant.

RESULTS

Of 237 sputum samples, 77.2% were mucoid in nature, followed by purulent and mucopurulent sputum in 16.9% and 5.9% of cases, respectively. In the purulent/mucopurulent samples, 85.2% showed positive growth on culture compared to 35% of mucoid samples. Cultures grew single pathogens in 108 cases, and 2 grew multiple pathogens; in 127 cases, no pathogenic organisms were isolated. In all, 41 (37.96%) isolates grew Gram-positive and 67 (62.04%) grew Gram-negative organisms. The most effective antibiotic against Gram-negative bacteria was imipenem (50%) and that against Gram-positive bacteria was vancomycin (70.59%). All isolates were resistant to ampicillin.

CONCLUSION

Sputum culture is a good and simple tool to study the aetiology and complications caused by bacteria in AECOPD. The antibiogram helps in identifying the correct treatment and timely initiation of appropriate antimicrobial therapy, thereby helping reduce mortality and morbidity.

摘要

背景

细菌感染是慢性阻塞性肺疾病急性加重(AECOPD)最常见的原因。这一情况可从自限性疾病到需要机械通气的呼吸衰竭,并且与幸存者死亡率和发病率增加相关。

目的

通过痰细菌培养和抗生素敏感性试验确定对AECOPD有效的常用抗生素。材料与方法:在本横断面观察性研究中,我们分析了237例在过去48小时内未接受过抗生素治疗患者的痰抗菌谱。进行了统计分析,并使用χ检验确定分类变量之间的关联。P值≤0.05被认为具有统计学意义。

结果

在237份痰标本中,77.2%为黏液性,其次为脓性痰和黏液脓性痰,分别占病例的16.9%和5.9%。在脓性/黏液脓性样本中,85.2%培养显示阳性生长,而黏液性样本为35%。培养出单一病原体的有108例,培养出多种病原体的有2例;127例未分离出致病生物。总共41株(37.96%)分离株为革兰氏阳性菌,67株(62.04%)为革兰氏阴性菌。对革兰氏阴性菌最有效的抗生素是亚胺培南(50%),对革兰氏阳性菌最有效的是万古霉素(70.59%)。所有分离株对氨苄西林耐药。

结论

痰培养是研究AECOPD中细菌病因和并发症的良好且简单的工具。抗菌谱有助于确定正确的治疗方法并及时开始适当的抗菌治疗,从而有助于降低死亡率和发病率。